you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01020 | SECTOR: Pharmaceuticals

BSE Live

Apr 20, 16:00
2153.00 -20.10 (-0.92%)
Volume
AVERAGE VOLUME
5-Day
19,511
10-Day
29,559
30-Day
16,172
9,468
  • Prev. Close

    2173.10

  • Open Price

    2209.00

  • Bid Price (Qty.)

    2141.10 (5)

  • Offer Price (Qty.)

    2180.00 (10)

NSE Live

Apr 20, 15:57
2155.70 -17.85 (-0.82%)
Volume
AVERAGE VOLUME
5-Day
334,818
10-Day
417,930
30-Day
281,347
231,993
  • Prev. Close

    2173.55

  • Open Price

    2200.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    2155.70 (33)

Financials

2020 2019 2018 2017 2016
Profit & Loss account of Ipca Laboratories (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 4,307.29 3,579.65 3,168.04 3,094.70 2,803.79  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 25.81 56.01 39.40  
Revenue From Operations [Net] 4,307.29 3,579.65 3,142.23 3,038.69 2,764.39  
Total Operating Revenues 4,367.43 3,633.15 3,193.40 3,102.21 2,803.66  
Other Income 64.69 54.59 39.54 20.65 27.67  
Total Revenue 4,432.12 3,687.74 3,232.94 3,122.86 2,831.33  
EXPENSES  
Cost Of Materials Consumed 1,431.10 1,098.02 923.20 947.31 886.01  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -155.05 -106.14 20.98 -1.73 22.26  
Employee Benefit Expenses 870.79 752.24 712.78 674.93 603.35  
Finance Costs 15.79 18.49 24.02 23.34 28.60  
Depreciation And Amortisation Expenses 178.69 171.88 174.36 171.00 161.23  
Other Expenses 1,101.18 1,027.99 926.50 887.97 880.10  
Total Expenses 3,647.15 3,130.35 2,950.14 2,864.66 2,719.88  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 784.97 557.39 282.80 258.20 111.45  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 784.97 557.39 282.80 258.20 111.45  
Tax Expenses-Continued Operations  
Current Tax 137.98 119.90 60.01 56.95 21.64  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -5.47 -12.40 -9.98 13.00 -2.71  
Tax For Earlier Years 0.00 -5.02 -0.34 -0.04 0.00  
Total Tax Expenses 132.51 102.48 49.69 69.91 18.93  
Profit/Loss After Tax And Before ExtraOrdinary Items 652.46 454.91 233.11 188.29 92.52  
Profit/Loss From Continuing Operations 652.46 454.91 233.11 188.29 92.52  
Profit/Loss For The Period 652.46 454.91 233.11 188.29 92.52  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 51.64 36.01 18.47 14.92 7.33  
Diluted EPS (Rs.) 51.60 36.01 18.47 14.92 7.33  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 257.80  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 472.84  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 4.44  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 28.66  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 101.08 12.64 12.62 0.00 12.62  
Tax On Dividend 20.77 2.60 2.56 0.00 2.57  
Equity Dividend Rate (%) 250.00 150.00 50.00 50.00 0.00  
Source : Dion Global Solutions Limited